Location · Port Orange, FL
Clinical trials in Port Orange, FL
33 recruiting studies have a site in Port Orange, and 3 of them accept healthy volunteers.
33 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Retension Pharmaceuticals. Inc.
- Location
- Port Orange, FL + 31 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Vedanta Biosciences, Inc.
- Location
- Port Orange, FL + 55 other US sites
- Eligibility basics
- Ages 12+
- RecruitingPhase 1
A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects
AdipoPharma LLC
- Location
- Port Orange, FL + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Hoffmann-La Roche
- Location
- Port Orange, FL + 58 other US sites
- Eligibility basics
- Ages 16–80
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Port Orange, FL + 104 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
CRISPR Therapeutics AG
- Location
- Port Orange, FL + 7 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
AstraZeneca
- Location
- Port Orange, FL + 5 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1/Phase 2
A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension
CRISPR Therapeutics AG
- Location
- Port Orange, FL
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Eli Lilly and Company
- Location
- Port Orange, FL + 41 other US sites
- Eligibility basics
- Ages 55+